SLI
1.984,39
PKT
-17,19
PKT
-0,86
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
20.01.21 | Holcim buy | UBS AG | |
20.01.21 | Holcim buy | UBS AG | |
20.01.21 | Novartis Neutral | Credit Suisse Group | |
20.01.21 | Roche Neutral | Credit Suisse Group | |
20.01.21 | Novartis buy | Jefferies & Company Inc. | |
20.01.21 | Roche buy | Jefferies & Company Inc. | |
19.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
18.01.21 | Nestlé buy | Goldman Sachs Group Inc. | |
18.01.21 | Holcim Hold | Jefferies & Company Inc. | |
18.01.21 | Zurich Insurance overweight | JP Morgan Chase & Co. | |
15.01.21 | Roche Hold | Deutsche Bank AG | |
15.01.21 | Novartis buy | Deutsche Bank AG | |
15.01.21 | UBS Equal weight | Barclays Capital | |
15.01.21 | UBS Underweight | Barclays Capital | |
15.01.21 | ABB (Asea Brown Boveri) Equal weight | Barclays Capital | |
15.01.21 | UBS buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
14.01.21 | UBS overweight | JP Morgan Chase & Co. | |
14.01.21 | Novartis buy | UBS AG | |
14.01.21 | Zurich Insurance overweight | Barclays Capital | |
14.01.21 | ams-OSRAM Underweight | Barclays Capital | |
14.01.21 | Holcim Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
13.01.21 | Zurich Insurance overweight | Morgan Stanley | |
13.01.21 | Novartis Underweight | JP Morgan Chase & Co. | |
13.01.21 | Roche Neutral | JP Morgan Chase & Co. | |
13.01.21 | Nestlé Sector Perform | RBC Capital Markets | |
12.01.21 | Givaudan Underperform | Bernstein Research | |
12.01.21 | Roche buy | UBS AG | |
12.01.21 | Nestlé buy | UBS AG | |
12.01.21 | Swiss Re Neutral | Credit Suisse Group | |
12.01.21 | ABB (Asea Brown Boveri) Underweight | JP Morgan Chase & Co. | |
12.01.21 | Nestlé overweight | JP Morgan Chase & Co. | |
12.01.21 | Givaudan Neutral | JP Morgan Chase & Co. | |
12.01.21 | ABB (Asea Brown Boveri) Sell | Deutsche Bank AG | |
11.01.21 | Holcim Hold | Jefferies & Company Inc. | |
08.01.21 | Holcim buy | UBS AG | |
08.01.21 | UBS Neutral | UBS AG | |
08.01.21 | UBS Sector Perform | RBC Capital Markets | |
08.01.21 | UBS overweight | JP Morgan Chase & Co. | |
08.01.21 | Novartis overweight | Morgan Stanley | |
08.01.21 | Roche Equal-Weight | Morgan Stanley |